1. Lactiplantibacillus plantarumDMDL 9010 alleviates dextran sodium sulfate (DSS)-induced colitis and behavioral disorders by facilitating microbiota-gut-brain axis balance
- Author
-
Ming-hua Liang, Yan-yan Huang, Dong-mei Liu, Jin Lin, Xiang-ze Jia, Ya-ping Wu, and Lan-fang Xiao
- Subjects
medicine.medical_specialty ,biology ,Chemistry ,Firmicutes ,Gut–brain axis ,Verrucomicrobia ,General Medicine ,medicine.disease ,biology.organism_classification ,Ulcerative colitis ,law.invention ,Butyric acid ,chemistry.chemical_compound ,Probiotic ,Endocrinology ,law ,Internal medicine ,medicine ,Colitis ,Neuroinflammation ,Food Science - Abstract
Previous studies have found that probiotic supplements could comfort mental behavioral disorders. This study investigated the effects of Lactiplantibacillus plantarum DMDL 9010 (LP9010) intake on the depression-like behavior induced by dextran sodium sulfate (DSS) and its possible mechanism. Male C57BL/6N mice were fed with DSS to establish the model of ulcerative colitis. LP9010 intake reduced DSS-induced inflammatory response, and repaired intestinal barrier damage, as well as lightened depression-like behavior. LP9010 supplementation also inhibited neuroinflammation by up-regulating the levels of neurotransmitters especially 5-HT, NE, DA, and 5-HIAA. Moreover, intake of LP9010 reorganized the gut microbiome by increasing the relative abundance of Bacteroidetes and Firmicutes, and decreasing the relative abundance of Proteobacteria and Verrucomicrobia. Furthermore, treatment with LP9010 also increased the levels of short-chain fatty acids such as butyric acid and propionic acid. In conclusion, LP9010 intake was a promising probiotic intervention strategy for the prevention of colitis-induced behavioral disorders through the microbiota-gut-brain axis.
- Published
- 2022
- Full Text
- View/download PDF